Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Topotecan HCl: Mechanistic Insight for Translational Oncolog
2026-07-13
Explore the strategic integration of Topotecan HCl as a topoisomerase 1 inhibitor in translational cancer research. This thought-leadership article dissects mechanistic depth, experimental validation, and translational workflows while addressing evidence-based best practices and future perspectives. By bridging advanced biological understanding with actionable protocol guidance, we empower researchers to optimize antitumor studies and accelerate clinical insight.
-
Lysis Buffer as a Rapid Genotyping Kit Component: Enhanced W
2026-07-13
Unlock high-integrity mouse genomic DNA extraction with optimized lysis buffer workflows. Explore practical enhancements, troubleshooting strategies, and translational insights for robust genetic analysis—bridging cutting-edge biomarker discovery with streamlined lab protocols.
-
Luminescent ATP Detection Assay Kit: Precision Cellular ATP
2026-07-12
The Luminescent ATP Detection Assay Kit enables ultrasensitive ATP quantification in biological samples using a firefly luciferase ATP assay. Its streamlined protocol and broad dynamic range (1 nM–10 μM) facilitate reproducible measurement of intracellular and tissue ATP levels. The kit’s compatibility with downstream analyses makes it a pivotal tool for energy metabolism assays.
-
CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce
2026-07-10
The CFDA SE Cell Tracer Kit is designed for robust, long-term fluorescent labeling of live cells, supporting applications such as cell proliferation studies and cell lineage tracing. It is best suited for workflows requiring stable, covalent cell marking and should not be used when reversible or short-term labeling is needed.
-
Exemestane: Steroidal Aromatase Inhibitor Workflows & Optimi
2026-07-09
Exemestane from APExBIO sets the standard for robust, irreversible inhibition of aromatase in translational breast cancer research. This guide delivers stepwise protocols, troubleshooting insights, and comparative workflow advantages for maximizing estrogen biosynthesis inhibition in the lab.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Precision W
2026-07-09
The JC-1 Mitochondrial Membrane Potential Assay Kit empowers researchers with sensitive, ratiometric detection of mitochondrial health, enabling robust apoptosis and drug response analysis. Learn how to unlock protocol precision, troubleshoot common pitfalls, and leverage innovations bridging mitochondrial function assays with advanced therapeutic research.
-
Carfilzomib (PR-171) in Myeloma: Proteasome Inhibition and E
2026-07-08
Explore how Carfilzomib (PR-171) advances multiple myeloma research through potent proteasome inhibition and its emerging role in combination epigenetic strategies. This article provides assay-focused insights, protocol guidance, and a unique analysis of recent breakthroughs.
-
DAMGO in Systems Neuropharmacology: Circuit Insights and Ass
2026-07-08
Explore how DAMGO, a selective µ-opioid receptor agonist, enables systems-level dissection of central opioid circuits and optimizes assay reliability in opioid receptor signaling research. This article uniquely bridges molecular selectivity with emerging circuit neuroscience for translational pain models.
-
Capecitabine in Advanced Tumor Assembloids: Protocols & Pitf
2026-07-07
Capecitabine’s targeted conversion and apoptosis induction make it indispensable for physiologically relevant preclinical oncology models. This guide dissects experimental workflows and troubleshooting strategies to maximize data fidelity in assembloid and organoid research.
-
Bradykinin B2 Receptors Inhibit Ileal Peristalsis in Guinea
2026-07-07
This study demonstrates that bradykinin B2 receptors mediate a specific inhibitory effect on the peristaltic reflex in the guinea pig ileum. The findings advance our mechanistic understanding of gastrointestinal motility regulation and provide a foundation for future pharmacological investigations relevant to both gastrointestinal and hypertension research.
-
Pazopanib (GW-786034): Mechanistic Depth and Predictive Biom
2026-07-06
Explore how Pazopanib (GW-786034) enables advanced cancer research through multi-targeted inhibition and predictive biomarker integration. This article offers a distinct, in-depth analysis of ATRX-deficient glioma vulnerability, assay optimization, and future directions.
-
Captopril’s Dual Impact: ACE Inhibition in Hypertension and
2026-07-06
Explore how Captopril’s precise ACE inhibition not only revolutionizes hypertension research but also opens new avenues in oncology via apoptosis induction. This article bridges mechanistic insights—such as bradykinin B2 receptor modulation of gut motility—with actionable guidance for translational researchers, distinguishing APExBIO’s Captopril as the gold standard for advanced experimental design.
-
Ceramides Promote Viral Replication via Autophagy in RGNNV I
2026-07-05
This study leverages global lipidomics to demonstrate that ceramides are crucial pro-viral mediators in red-spotted grouper nervous necrosis virus (RGNNV) infection. By elucidating the mechanistic link between ceramide metabolism and autophagy, the research suggests new avenues for antiviral strategies in aquaculture.
-
Troglitazone: Applied PPARγ Agonist Workflows in Tumor and M
2026-07-04
Troglitazone is a dual PPARγ/α agonist empowering both type 2 diabetes and anti-tumor studies through precise modulation of nuclear receptor pathways. This article delivers protocol-driven, literature-backed strategies and troubleshooting tips for maximizing reproducibility and biological insight using APExBIO’s high-purity troglitazone.
-
EdU Imaging Kits (488): Reliable S-Phase DNA Synthesis Detec
2026-07-03
EdU Imaging Kits (488) enable sensitive, DNA synthesis-specific cell proliferation assays using 5-ethynyl-2'-deoxyuridine and click chemistry. These kits outperform traditional BrdU assays by preserving cell integrity and improving workflow efficiency. Their validated performance supports advanced applications in research and diagnostics.